Inflammatory mechanisms are active in the Alzheimer's disease (AD) brain. Studies that range from epidemiological surveys to therapeutic trials in transgenic mice provide growing support for the theory that antiinflammatory drugs may be useful in the prevention and/or treatment of the disease. Randomized controlled trials in humans have not yet confirmed this theory. However, prevention and treatment trials continue to test specific antiinflammatory strategies for AD. © 2002 Wiley-Liss, Inc.
CITATION STYLE
Aisen, P. S. (2002, July 1). Development of antiinflammatory therapy for Alzheimer’s disease. Drug Development Research. https://doi.org/10.1002/ddr.10094
Mendeley helps you to discover research relevant for your work.